Poly(α-hydroxyacids) for application in the spinal cord: Resorbability and biocompatibility with adult rat schwann cells and spinal cord

Journal of Biomedical Materials Research

Volumn 42, Issue 4, 1998, Pages 642-654

  Gautier, Sandrine E ^a   Oudega, Martin ^b   Fragoso, Miryam ^a   Chapon, Pascal ^a   Plant, Giles W ^b   Bunge, Mary Bartlett ^b,c   Parel, Jean Marie ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Axonal regeneration; Biocompatibility; Biodegradable implants; Lactic and glycolic acid polymers; Schwann cells

Indexed keywords

BIOCOMPATIBILITY; BIOMECHANICS; BONE; CELLS; NEUROLOGY; ORGANIC POLYMERS;

AXONAL REGENERATION; BIODEGRADABLE IMPLANTS; POLYHYDROXYACIDS; SCHWANN CELLS;

IMPLANTS (SURGICAL);

NEUROMODULIN; POLY(2 HYDROXYACID); POLYGLACTIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BIOCOMPATIBILITY; CELL SURVIVAL; FEMALE; HISTOPATHOLOGY; MOLECULAR WEIGHT; NERVE REGENERATION; NONHUMAN; PROSTHESIS MATERIAL; RAT; SCHWANN CELL; SPINAL CORD;

ANIMALS; BIOCOMPATIBLE MATERIALS; BIOTRANSFORMATION; CELLS, CULTURED; FEMALE; HUMANS; INFLAMMATION; LACTIC ACID; MACROPHAGES; MONOCYTES; POLYGLYCOLIC ACID; POLYMERS; RATS; RATS, INBRED F344; SCHWANN CELLS; SPINAL CORD; SPINAL CORD INJURIES; TIME FACTORS;

EID: 0032534633     PISSN: 00219304     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4636(19981215)42:4<642::AID-JBM22>3.0.CO;2-K     Document Type: Article

References (61)

1. C. H. Tator and M. G. Fehlings, "Review of the secondary injury theory of spinal cord trauma with emphasis on vascular mechanisms," J. Neurosurg., 75, 15-26 (1991).
2. H. D. Demopoulos, E. S. Flamm, and D. D. Rietronigro, "The free radical pathology and the microcirculation in the major central nervous system disorders," Acta Physiol. Scand., 492, 91-119 (1980).
3. E. D. Hall, "Inhibition of lipid peroxidation in CNS trauma," J. Neurotrauma, S31-S40 (1991).
4. A. R. Blight, "Delayed demyelination and macrophage invasion: A candidate for secondary cell damage in spinal cord injury," Centr. Nerv. Syst. Trauma, 2, 299-315 (1985).
5. I. Dusart and M. E. Schwab, "Secondary cell death and inflammatory reaction after dorsal hemisection of the rat spinal cord," Eur. J. Neurosci., 6, 712-724 (1994).
6. M. B. Bracken, M. J. Shepard, and W. F. Collins, "A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal cord injury," N. Engl. J. Med., 322, 1405-1411 (1990).
7. E. D. Hall, "The neuroprotective pharmacology of methylprednisolone," J. Neurosurg., 76, 13-22 (1992).
8. A. Chen, X. M. Xu, N. Kleitman, and M. B. Bunge, "Methyl-prednisolone administration improves axonal regeneration into SC grafts in thoracic rat spinal cord," Exp. Neural., 138, 261-276 (1996).
9. M. Oudega, C. G. Vargas, A. B. Weber, N. Kleitman, and M. B. Bunge, "Methylprednisolone reduces tissue loss and improves axonal sprouting in the transected adult rat spinal cord," to appear.
10. V. Guénard, X. M. Xu, and M. B. Bunge, "The use of Schwann cell transplantation to foster central nervous system repair," Sem. Neurosci., 5, 401-411 (1993).
11. X. M. Xu, V. Guénard, N. Kleitman, and M. B. Bunge, "Axonal regeneration into Schwann cell-seeded guidance channels grafted into transected adult rat spinal cord," J. Comp. Neurol., 351, 145-160 (1995).
12. X. M. Xu, V. Guénard, N. Kleitman, P. Aebischer, and M. B. Bunge, "A combination of BDNF and NT-3 promotes supraspinal axonal regeneration into Schwann cell grafts in adult rat thoracic spinal cord," Exp. Neurol., 134, 261-272 (1995).
13. X. M. Xu, A. Chen, V. Guénard, N. Kleitman, and M. B. Bunge, "Bridging Schwann cell transplants promote axonal regeneration from both the rostral and caudal stumps of transected adult rat spinal cord," J. Neurocytol., 26, 1-16 (1997).
14. M. Oudega, X. M. Xu, V. Guénard, N. Kleitman, and M. B. Bunge, "A combination of insulin-like growth factor-I and platelet-derived growth factor enhances myelination but diminishes axonal regeneration into Schwann cell grafts in the adult rat spinal cord," Glia, 19, 247-258 (1997).
15. J. M. Pachence and J. Kohn, "Biodegradable polymers for tissue engineering," in Principles of Tissue Engineering, R. P. Lanza, R. Langer, and W. L. Chick (eds.), R. G. Landes Co. and Academic Press, Inc., Austin, 1997, pp. 273-294.
16. M. Vert, P. Christel, F. Chabot, and J. Leray, "Bioresorbable plastic materials for bone surgery," in Macromolecular Materials, G. W. Hastings and P. Ducheyne (eds.), CRC Press, Inc., Boca Raton, Florida, 1984.
17. K. A. Athanasiou, G. G. Niederauer, and C. M. Agrawal, "Sterilization, toxicity, biocompatibility and clinical applications of polylactic/polyglycolic acid copolymers," Biomaterials, 17, 93-102 (1996).
18. M. Vert, S. M. Li, and H. Garreau, "Attempts to map the structure and degradation characteristics of aliphatic polyesters derived from lactic and glycolic acids," Biomater. Sci., Polym, Edn., 6, 639-649 (1994).
19. P. Robert, J. Mauduit, R. M. Frank, and M. Vert, "Biocompatibility and resorbability of a polylactic acid membrane for periodontal guided tissue regeneration," Biomaterials, 14, 353-358 (1993).
20. G. G. Giordano, R. C. Thompson, S. L. Ishaug, A. G. Mikos, S. Cumber, C. A. Garcia, and D. Lahiri-Munir, "Retinal pigment epithelium cells cultured on synthetic biodegradable polymers," J. Biomed. Mater. Res., 34, 87-93 (1997).
21. R. C. Thomson, M. J. Yaszemski, and A. G. Mikos, "Polymer scaffold processing," in Principles of Tissue Engineering, R. P. Lanza, R. Langer, and W. L. Chick (eds.), R. G. Landes and Academic Press, Inc., Austin, 1997, pp. 263-272.
22. A. G. Mikos, A. J. Thorsen, and L. A. Czerwonka, "Preparation and characterization of poly(L-lactic acid) foams," Polymer, 35, 1068-1077 (1994).
23. C. Schugens, V. Maquet, C. Granfils, R. Jérôme, and P. Teyssié, "Biodegradable and macroporous polylactide implants for cell transplantation. I. Preparation of macroporous polylactide supports by solid-liquid phase separation," Polymer, 37, 1027-1038 (1996).
24. C. Schugens, V. Maquet, C. Grandfils, R. Jérôme, and P. Teyssié, "Polylactide macroporous biodegradable implants for cell transplantation. II. Preparation of polylactide foams by liquid-liquid phase separation," J. Biomed. Mater. Res., 30, 449-461 (1996).
25. Y. J. Park, K. H. Nam, S. J. Ha, C. M. Pai, C. P. Chung, and S. J. Lee, "Porous poly(L-lactide) membranes for guided tissue regeneration and controlled drug delivery: Membrane fabrication and characterization," J. Controlled Release, 43, 151-160 (1997).
26. L. G. Cima, J. P. Vacanti, C. Vacanti, D. Ingber, D. Mooney, and R. Langer, "Tissue engineering by cell transplantation using degradable polymer substrates," J. Biomech. Eng., 113, 143-150 (1991).
27. M. W. Davis and J. P. Vacanti, "Toward development of an implantable tissue engineered liver," Biomaterials, 17, 365-372 (1996).
28. M. C. Wake, C. W. Patrick, and A. G. Mikos, "Pore morphology effects on the fibrovascular tissue growth in porous polymer substrates," Cell Transplant., 3, 339-343 (1994).
29. D. J. Mooney, G. Organ, J. P. Vacanti, and R. Langer, "Design and fabrication of biodegradable polymer devices to engineer tubular tissues," Cell Transplant., 3, 203-210 (1994).
30. G. Beumer, C. A. van Blitterswik, and M. Ponec, "Biocompatibility of a biodegradable matrix used as a skin substitute: An in vivo evaluation," J. Biomed. Mater. Res., 28, 545-552 (1994).
31. A. Atala, M. R. Freeman, J. P. Vacanti, J. Shepard, and A. B. Retik, "Implantation in vivo and retrieval of artificial structures consisting of rabbit and human urothelium and human bladder muscle," J. Urol, 150, 608-612 (1993).
32. L. de Medinaceli, R. A. Khoury, and M. Merle, "Large amounts of polylactic acid in contact with divided nerve sheaths have no adverse effects on regeneration," J. Reconstr. Microsurg., 11, 43-49 (1995).
33. P. Menei, V. Daniel, C. Montero-Menei, M. Brouillard, A. Pouplart-Barthelaix, and J.-P. Benoît, "Biodegradation and brain tissue reaction to poly(D,L-lactide-co-glycolide) microspheres," Biomaterials, 14, 470-478 (1993).
34. R. L. Reid, D. E. Cutright, and J. S. Garrison, "Biodegradable cuff as adjunct to peripheral nerve repair: A study in dogs," Hand, 10, 259-266 (1978).
35. E. Nyilas, T.-H. Chiu, R. L. Sidman, E. W. Henry, T. M. Brushart, P. Dikkes, and R. Madison, "Peripheral nerve repair with biodegradable prostheses," Trans. Am. Sac. Artif. Intern. Org., 29, 307-312 (1983).
36. H. Molander, Y. Olsson, O. Engkvist, S. Bowald, and I. Eriksson, "Regeneration of peripheral nerve through a polyglactin tube," Muscle Nerve, 5, 54-57 (1982).
37. B. Rutledge Seckel, T. H. Chiu, E. Nyilas, and R. L. Sidman, "Nerve regeneration through synthetic biodegradable nerve guides: Regulation by the target organ," Plast. Reconstr. Surg., 74, 173-181 (1984).
38. E. W. Henry, T. H. Chiu, E. Nyilas, T. M. Brushart, P. Dikkes, and R. L. Sidman, "Nerve regeneration through biodegradable polyester tubes," Exp. Neural., 90, 652-676 (1985).
39. R. D. Madison, C. da Silva, P. Dikkes, R. L. Sidman, and T.-H. Chiu, "Peripheral nerve regeneration with entubulation repair: Comparison of biodegradable nerve guides versus polyethylene tubes and the effects of a laminin-containing gel," Exp. Neural., 95, 378-390 (1987).
40. A. Lee Dellon and S. E. MacKinnon, "An alternative to the classical nerve graft for the management of the short nerve gap," Plast. Reconstr. Surg., 82, 849-856 (1988).
41. H.J. Hoppen, J. W. Leenslag, A. J. Pennings, B. van der Lei, and P. H. Robinson, "Two-ply biodegradable nerve guide: Basic aspects of design, construction and biological performance," Biomaterials, 11, 286-289 (1990).
42. P. Robinson, B. van der Lei, H. J. Hoppen, J. W. Leenslag, A. J. Pennings, and P. Nieuwenhuis, "Nerve regeneration through a two-ply biodegradable nerve guide in the rat and the influence of ACTH4-9 nerve growth factor," Microsurgery, 12, 412-419 (1991).
43. W. F. A. den Dunnen, B. van der Lei, J. M. Schakenraad, E. H. Blaauw, I. Stokroos, A. J. Pennings, and P. H. Robinson, "Long-term evaluation of nerve regeneration in a biodegradable nerve guide," Microsurgery, 14, 508-515 (1993).
44. W. F. A. den Dunnen, J. M. Shakenraad, G. J. Zondervan, A. J. Pennings, B. van der Lei, and P. H. Robinson, "A new PLLA/ PCL copolymer for nerve regeneration," J. Mater. Sci. Mater. Med., 4, 521-525 (1993).
45. W. F. A. den Dunnen, B. van der Lei, P. H. Robinson, A. Holwerda, A. J. Pennings, and J. M. Schakenraad, "Biological performance of a degradable poly(lactic acid-ε-caprolactone) nerve guide: Influence of tube dimensions," J. Biomed. Mater. Res., 29, 757-766 (1995).
46. N. Nicoli Aldini, G. Perego, G. D. Cella, M. C. Maltarello, M. Fini, M. Rocca, and R. Giardino, "Effectiveness of a bioabsorbable conduit in the repair of peripheral nerves," Biomaterials, 17, 959-962 (1996).
47. S. E. MacKinnon and A. Lee Dellon, "Clinical nerve reconstruction with a bioabsorbable polyglycolic acid tube," Plast. Reconstr. Surg., 85, 419-423 (1988).
48. R. F. Valentini and P. Aebischer, "Strategies for the engineering of peripheral nervous tissue regeneration," in Principles of Tissue Engineering, R. P. Lanza, R. Langer, and W. L. Chick (eds.), R. G. Landes and Academic Press, Inc., Austin, 1997, pp. 671-684.
49. J. H. Kou, C. Emmett, P. Shen, S. Aswani, T. Iwamoto, F. Vaghefi, G. Cain, and L Sanders, "Bioerosion and biocompatibility of poly(D,L-lactic-co-glycolic acid) implants in the brain," J. Controlled Release, 43, 123-130 (1997).
50. P. Menei, J. P. Benoît, M. Boisdron-Celle, D. Fournier, P. Mercier, and G. Guy, "Drug targeting into the central nervous system by stereotactic implantation of biodegradable microspheres," Neurosurgery, 34, 1058-1064 (1994).
51. J.-P. Benoît, P. Menei, M. Boisdron, E. Gamelin, and G. Guy. "Radiosensitization of glioblastoma after intracranial implantation of biodegradable 5-FU-loaded microspheres: Phase I/II clinical trial," Proc. Int. Symp. Controlled Release Bioact. Mater., 24, 995 (1997).
52. H. A. von Recum, R. L. Cleek, S. G. Eskin, and A. G. Mikos, "Degradation of polydispersed poly(L-lactic acid) to modulate lactic acid release," Biomaterials, 16, 441-447 (1995).
53. K. Jamshidi, S.-H. Hyon, and T. Ikada, "Thermal characterization of polylactides," Polymer 29, 2229-2234 (1988).
54. M. Thérin, P. Christel, S. M. Li, and M. Vert, "In vivo degradation of massive poly(α-hydroxyacids): Validation of in vitro findings," Biomaterials, 13, 594-600 (1992).
55. I. Grizzi, H. Garreau, S. M. Li, and M. Vert, "Hydrolytic degradation of devices based on poly(D,L-lactic acid): Size dependence," Biomaterials, 16, 305-311 (1995).
56. A. Celli and M. Scandola, "Thermal properties and physical ageing of poly(L-lactic acid)," Polymer, 33, 2699-2703 (1992).
57. M. Oudega and T. Hagg, "Nerve growth factor promotes regeneration of sensory axons into adult rat spinal cord," Exp. Neural, 140, 218-229 (1996).
58. R. Bodmeier, K. H. Oh, and H. Chen. "The effect of the addition of low molecular weight poly(DL-lactide) on drug release from biodegradable poly(DL-lactide) drug delivery systems," Int. J. Pharmaceut., 51, 1-8 (1989).
59. J. Mauduit, E. Pérouse, and M. Vert, "Hydrolytic degradation of films prepared from blends of high and low molecular weight poly(D,L-lactic)s," J. Biomed. Mater. Res., 30, 201-207 (1996).
60. C. Grandfils, P. Flandroy, and R. Jérôme, "Control of the biodegradation rate of poly(D,L-lactide) microparticles intended as chemoembolization materials," J. Controlled Release, 38, 109-122 (1996).
61. R. A. Kenley, M. Ott Lee, T. R. Mahoney, and L. M. Sanders, "Poly(lactide-co-glycolide) decomposition kinetics in vivo and in vitro," Macromolecules, 20, 2398-2403 (1987).